Predictive Value of Preoperative Rectus and Diaphragm Muscle Thickness for Postoperative Complications in Gastrointestinal Cancer Surgery
NCT ID: NCT07098871
Last Updated: 2025-12-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2025-09-01
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main research question is whether rectus abdominis and diaphragm muscle thickness can be used to predict postoperative complications in these patients, and whether there are specific cut-off values for these muscle thicknesses.
Participants will be selected from operable gastrointestinal malignancy cases, and preoperative measurements of rectus abdominis and diaphragm muscle thickness will be performed using ultrasonography.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Gastrointestinal system (GIS) malignancies are commonly encountered and carry a significant risk of serious complications following surgery. Therefore, several studies in the literature have focused on identifying parameters that can predict the risk of postoperative complications in patients undergoing surgery for GIS malignancies. Some publications have suggested that preoperative nutritional indices may help predict the development of complications, evaluating specific parameters through biochemical tests or radiological assessments of muscle and fat mass.
In our study, we aim to investigate the relationship between preoperative rectus abdominis and diaphragm muscle thickness-measured via ultrasonography during routine fascial block procedures-and the rate of complications occurring within the first 30 days postoperatively in patients undergoing surgery for GIS malignancies.
Methodology:
Patients whose rectus abdominis and diaphragm muscle thickness were measured during routine preoperative fascial block ultrasonography will be included in the study. No additional intervention or procedure is planned; patients will be evaluated as part of standard clinical practice, and their postoperative outcomes will be recorded observationally. No additional tests requiring reimbursement from the national health insurance system will be performed as part of the study.
Study Hypotheses:
H₀ (Null Hypothesis): There is no significant difference in rectus abdominis and diaphragm muscle thickness between patients who develop complications within the first 30 days after GIS malignancy surgery and those who do not.
H₁ (Alternative Hypothesis): There is a significant difference in rectus abdominis and diaphragm muscle thickness between patients who develop complications within the first 30 days after GIS malignancy surgery and those who do not.
Data Collection Tools:
Data will be collected prospectively from routine clinical evaluations. Ultrasonographic measurements of rectus abdominis and diaphragm muscle thickness will be performed by the researchers during routine preoperative fascial block procedures. No additional tests or procedures requiring reimbursement from SGK will be performed. Patient identities and personal data will be kept confidential by the researchers, and all procedures carried out within the study will pose no additional risk to the patients.
Statistical Analysis:
Data obtained from the study will be analyzed using SPSS (Statistical Package for the Social Sciences) version 25.0 (IBM Corp., Armonk, NY, USA). Descriptive statistics (e.g., number, percentage, median) will be used to summarize the data. Quantitative variables will be evaluated using the t-test or Mann-Whitney U test, while categorical variables will be analyzed using the chi-square test or Fisher's exact test. The relationship between rectus and diaphragm muscle thickness and the development of complications will be assessed using receiver operating characteristic (ROC) curve analysis. A p-value of \<0.05 will be considered statistically significant, and 95% confidence intervals will be reported.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgery
Patients undergone surgery for gastrointestinal system malignancies
Ultrasonography (Rectus and diaphragma muscle thickness measurement)
Rectus and diaphragma muscle thickness will be measured by ultrasonography preoperatively.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasonography (Rectus and diaphragma muscle thickness measurement)
Rectus and diaphragma muscle thickness will be measured by ultrasonography preoperatively.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients scheduled for laparoscopic or open surgery due to GIS malignancy between 01.05.2025 and 01.11.2025
* Postoperative follow-up at our center for a minimum of 30 days
Exclusion Criteria
* Patients not undergoing surgery
* Patients undergoing surgery for indications other than GIS malignancy
* Patients with follow-up data shorter than 30 days
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Oncology Research and Training Hospital
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Burak Dincer
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Oncology Training and Research Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-03/50
Identifier Type: -
Identifier Source: org_study_id